![](https://static.biospace.com/dims4/default/86b1c81/2147483647/strip/true/crop/622x350+1+0/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F5DC1FBCB-BB96-4730-8108-00C489E22A23.jpg)
Merck KGaA Courts Cancer Biotech SpringWorks for Potential Buyout
German pharma Merck KGaA is currently in “advanced discussions” with SpringWorks Therapeutics regarding a potential acquisition. The news, first reported by Reuters Monday and confirmed by Merck KGaA a few hours later, sent the cancer biotech’s stocks …